Universal Health: Bollinger Bands Narrowing, Bearish Marubozu on 15min Chart
PorAinvest
viernes, 12 de septiembre de 2025, 3:23 pm ET1 min de lectura
UHS--
Institutional Investment Activity
Focus Partners Advisor Solutions LLC recently acquired 2,322 shares of UHS, valued at approximately $436,000, according to their latest filing with the SEC [1]. Other institutional investors have also shown interest in UHS. Ameriprise Financial Inc. increased its position by 329.4% in the first quarter, owning 404,806 shares worth $76,081,000. Twinbeech Capital LP grew its stake by 1,151.1% in the fourth quarter, holding 152,454 shares worth $27,353,000. GAMMA Investing LLC increased its holdings by 16,935.6% in the first quarter, owning 138,670 shares worth $26,056,000. Nuveen LLC bought a new stake valued at about $25,555,000 in the first quarter, and Man Group plc raised its stake by 307.5% in the fourth quarter, holding 178,648 shares worth $32,053,000 [1].
Analyst Ratings and Price Targets
Several research firms have weighed in on UHS. Wall Street Zen upgraded UHS from a "buy" to a "strong-buy" rating. Royal Bank Of Canada raised its price objective from $201.00 to $206.00. Cantor Fitzgerald reiterated a "neutral" rating with a $227.00 price objective. Robert W. Baird dropped its target price from $243.00 to $203.00. Wells Fargo & Company cut its price target from $225.00 to $210.00 [1].
Financial Performance
UHS reported $5.35 EPS for the quarter, beating analysts' estimates of $4.85 by $0.50. The company's revenue was $4.28 billion, up 9.6% year-over-year. The company has set its FY 2025 guidance at 20.000-21.000 EPS [1].
Technical Indicators
The 15-minute chart of UHS on September 12, 2025, at 15:15, exhibited Bollinger Bands Narrowing and a Bearish Marubozu formation. This indicates a decrease in price volatility and suggests that sellers are currently controlling the market. The Bearish Marubozu formation, characterized by a large body and no upper or lower shadows, suggests a strong downward trend [1].
Conclusion
Universal Health Services has seen increased institutional investment and recent technical analysis trends suggesting a potential continuation of bearish momentum. Analysts have provided varied ratings and price targets, with some upgrades and others maintaining a hold position. Investors should closely monitor UHS's earnings report and future price movements.
UHT--
Universal Health's 15-minute chart has recently exhibited characteristics of Bollinger Bands Narrowing and a Bearish Marubozu formation on September 12, 2025 at 15:15. This trend suggests a decrease in the magnitude of stock price fluctuations, indicating that sellers are currently controlling the market. Furthermore, this bearish momentum is likely to persist.
Universal Health Services, Inc. (UHS) has been the subject of significant institutional investment activity and recent technical analysis trends. On September 12, 2025, at 15:15, UHS exhibited characteristics of Bollinger Bands Narrowing and a Bearish Marubozu formation, suggesting a decrease in price volatility and a potential continuation of bearish momentum [1].Institutional Investment Activity
Focus Partners Advisor Solutions LLC recently acquired 2,322 shares of UHS, valued at approximately $436,000, according to their latest filing with the SEC [1]. Other institutional investors have also shown interest in UHS. Ameriprise Financial Inc. increased its position by 329.4% in the first quarter, owning 404,806 shares worth $76,081,000. Twinbeech Capital LP grew its stake by 1,151.1% in the fourth quarter, holding 152,454 shares worth $27,353,000. GAMMA Investing LLC increased its holdings by 16,935.6% in the first quarter, owning 138,670 shares worth $26,056,000. Nuveen LLC bought a new stake valued at about $25,555,000 in the first quarter, and Man Group plc raised its stake by 307.5% in the fourth quarter, holding 178,648 shares worth $32,053,000 [1].
Analyst Ratings and Price Targets
Several research firms have weighed in on UHS. Wall Street Zen upgraded UHS from a "buy" to a "strong-buy" rating. Royal Bank Of Canada raised its price objective from $201.00 to $206.00. Cantor Fitzgerald reiterated a "neutral" rating with a $227.00 price objective. Robert W. Baird dropped its target price from $243.00 to $203.00. Wells Fargo & Company cut its price target from $225.00 to $210.00 [1].
Financial Performance
UHS reported $5.35 EPS for the quarter, beating analysts' estimates of $4.85 by $0.50. The company's revenue was $4.28 billion, up 9.6% year-over-year. The company has set its FY 2025 guidance at 20.000-21.000 EPS [1].
Technical Indicators
The 15-minute chart of UHS on September 12, 2025, at 15:15, exhibited Bollinger Bands Narrowing and a Bearish Marubozu formation. This indicates a decrease in price volatility and suggests that sellers are currently controlling the market. The Bearish Marubozu formation, characterized by a large body and no upper or lower shadows, suggests a strong downward trend [1].
Conclusion
Universal Health Services has seen increased institutional investment and recent technical analysis trends suggesting a potential continuation of bearish momentum. Analysts have provided varied ratings and price targets, with some upgrades and others maintaining a hold position. Investors should closely monitor UHS's earnings report and future price movements.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios